AGP Executive Report
Last update: 9 hours agoBiopharma Deal: Hansa Biopharma has struck an exclusive licensing agreement with SERB for IDEFIRIX (imlifidase) across the EU, UK, Switzerland, Norway, Liechtenstein, Iceland and MENA, with SERB paying €110m upfront plus €5m tied to EMA filing acceptance—aimed at desensitising highly sensitised kidney transplant patients. Green Diplomacy: In Oslo, PM Narendra Modi and Nordic leaders are pushing a “green strategic partnership” focused on clean energy, climate resilience, the blue economy and green shipping, with Norway’s renewable-heavy power mix paired against India’s scale and speed. Business Climate: Norwegian firms told Modi to tackle “ground level” regulatory friction to improve ease of doing business, alongside trade and tech cooperation. Mobility & Travel Rules: The UK is expanding airport e-gates for children aged eight and nine from 8 July, potentially easing summer queues for up to 1.5m more kids. Wealth Management: LGT has appointed a new Thailand wealth chief executive, underscoring Thailand’s growing pull for private banking.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result.
Perspectify News
